Publication: A New Hydrazide-Hydrazone Based Schiff Base: Synthesis, DFT Calculations, in Silico Pharmacokinetics and Toxicity, Inhibitory Activity Against Tau Aggregation and SARS-CoV Mpro
| dc.authorscopusid | 55622925500 | |
| dc.authorscopusid | 57201620841 | |
| dc.contributor.author | Şahin, Ş. | |
| dc.contributor.author | Dege, N. | |
| dc.date.accessioned | 2025-12-11T00:31:54Z | |
| dc.date.issued | 2023 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Şahin] Songül, Department of Physics, Arts and Sciences Faculty, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Dege] Necmi, Department of Physics, Ondokuz Mayis Üniversitesi, Samsun, Turkey | en_US |
| dc.description.abstract | We report here a new imine compound (Schiff base) with a hydrazide-hydrazone moiety, N'-(5-nitro-2-(piperidin-1-yl)benzylidene)benzohydrazide. The present work deals with synthesis, spectral and structural characterization, in silico drug-likeness, target identification, and molecular docking studies of this compound. In this study, structural characterization was performed using complementary spectroscopic techniques, including X-ray, FT-IR,1H-NMR, and UV-Vis. Surface properties and electronic studies were investigated using the method DFT/B3LYP. Drug-likeness, physicochemical and pharmacokinetic (ADME) properties, toxicity evaluation, and biological target identification were fulfilled using some bioinformatics and cheminformatics web tools. Draggability studies indicated two biological targets for our compound: microtubule-associated protein tau and protease, and docking studies were performed on tau fibrils (5V5C and 3OVL) and Mpro (6LU7) of SARS-CoV-2 accordingly. © 2023, Iranian Institute of Research and Development in Chemical Industries. All rights reserved. | en_US |
| dc.identifier.doi | 10.30492/ijcce.2022.559865.5508 | |
| dc.identifier.endpage | 2465 | en_US |
| dc.identifier.issn | 1021-9986 | |
| dc.identifier.issue | 8 | en_US |
| dc.identifier.scopus | 2-s2.0-85188461712 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 2451 | en_US |
| dc.identifier.uri | https://doi.org/10.30492/ijcce.2022.559865.5508 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/37072 | |
| dc.identifier.volume | 42 | en_US |
| dc.identifier.wosquality | Q3 | |
| dc.language.iso | en | en_US |
| dc.publisher | Iranian Institute of Research and Development in Chemical Industries | en_US |
| dc.relation.ispartof | Iranian Journal of Chemistry & Chemical Engineering-International English Edition | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | COVID-19 | en_US |
| dc.subject | Hydrazide and Hydrazone | en_US |
| dc.subject | SARS-CoV-2 | en_US |
| dc.subject | Schiff Base: Molecular Docking | en_US |
| dc.subject | Tau Aggregation | en_US |
| dc.title | A New Hydrazide-Hydrazone Based Schiff Base: Synthesis, DFT Calculations, in Silico Pharmacokinetics and Toxicity, Inhibitory Activity Against Tau Aggregation and SARS-CoV Mpro | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |
